13-111342850-A-C

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_152324.3(TEX29):ā€‹c.334A>Cā€‹(p.Ser112Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000062 in 1,614,198 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.00032 ( 0 hom., cov: 32)
Exomes š‘“: 0.000035 ( 0 hom. )

Consequence

TEX29
NM_152324.3 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.703
Variant links:
Genes affected
TEX29 (HGNC:20370): (testis expressed 29) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.007236302).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TEX29NM_152324.3 linkuse as main transcriptc.334A>C p.Ser112Arg missense_variant 5/6 ENST00000283547.2 NP_689537.1 Q8N6K0
TEX29NM_001303133.1 linkuse as main transcriptc.403A>C p.Ser135Arg missense_variant 6/7 NP_001290062.1 Q8N6K0
TEX29XM_017020387.2 linkuse as main transcriptc.415A>C p.Ser139Arg missense_variant 5/6 XP_016875876.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TEX29ENST00000283547.2 linkuse as main transcriptc.334A>C p.Ser112Arg missense_variant 5/61 NM_152324.3 ENSP00000283547.1 Q8N6K0
TEX29ENST00000497241.5 linkuse as main transcriptn.*305A>C non_coding_transcript_exon_variant 6/75 ENSP00000431661.1 F2Z350
TEX29ENST00000497241.5 linkuse as main transcriptn.*305A>C 3_prime_UTR_variant 6/75 ENSP00000431661.1 F2Z350

Frequencies

GnomAD3 genomes
AF:
0.000322
AC:
49
AN:
152192
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00116
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000954
AC:
24
AN:
251458
Hom.:
0
AF XY:
0.0000662
AC XY:
9
AN XY:
135918
show subpopulations
Gnomad AFR exome
AF:
0.00135
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000349
AC:
51
AN:
1461888
Hom.:
0
Cov.:
31
AF XY:
0.0000303
AC XY:
22
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.00140
Gnomad4 AMR exome
AF:
0.0000447
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.000322
AC:
49
AN:
152310
Hom.:
0
Cov.:
32
AF XY:
0.000282
AC XY:
21
AN XY:
74468
show subpopulations
Gnomad4 AFR
AF:
0.00115
Gnomad4 AMR
AF:
0.0000653
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000836
Hom.:
0
Bravo
AF:
0.000442
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000140
AC:
17
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 06, 2024The c.334A>C (p.S112R) alteration is located in exon 5 (coding exon 4) of the TEX29 gene. This alteration results from a A to C substitution at nucleotide position 334, causing the serine (S) at amino acid position 112 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
2.8
DANN
Uncertain
0.98
DEOGEN2
Benign
0.026
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.0087
N
LIST_S2
Benign
0.38
T
M_CAP
Benign
0.00080
T
MetaRNN
Benign
0.0072
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.20
N
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.0020
Sift
Benign
0.24
T
Sift4G
Benign
0.31
T
Polyphen
0.21
B
Vest4
0.079
MutPred
0.30
Loss of phosphorylation at S112 (P = 0.008);
MVP
0.014
MPC
0.66
ClinPred
0.013
T
GERP RS
-2.7
Varity_R
0.070
gMVP
0.025

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139725878; hg19: chr13-111995197; API